Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Case Study: Patient With Severe AD, Type 2 Inflammatory Comorbidities Rapidly Improves With Dupilumab
07/19/2021
Jolynn Tumolo
“To our knowledge, this case is the first report describing rapid, successful treatment of severe atopic dermatitis and comorbid type 2 inflammatory diseases in the same patient, with dupilumab treatment, with no side-effects,” researchers...
“To our knowledge, this case is the first report describing rapid, successful treatment of severe atopic dermatitis and comorbid type 2 inflammatory diseases in the same patient, with dupilumab treatment, with no side-effects,” researchers...
“To our knowledge, this case is...
07/19/2021
First Report Managed Care
News
Patients With DLBCL Made Up Majority of CAR T-Cell Therapy Hospitalizations in 2018
07/19/2021
Jolynn Tumolo
A recent study looked at real-world outcomes of patients hospitalized to receive CAR T-cell therapy for DLBCL, primary mediastinal large B-cell lymphoma, and B-cell precursor acute lymphoblastic leukemia.
A recent study looked at real-world outcomes of patients hospitalized to receive CAR T-cell therapy for DLBCL, primary mediastinal large B-cell lymphoma, and B-cell precursor acute lymphoblastic leukemia.
A recent study looked at...
07/19/2021
First Report Managed Care
News
Chemotherapy Agent Recalled
07/16/2021
Jolynn Tumolo
The FDA is recalling a chemotherapy injection used to treat cancer of the ovary, lung, and cervix.
The FDA is recalling a chemotherapy injection used to treat cancer of the ovary, lung, and cervix.
The FDA is recalling a...
07/16/2021
Pharmacy Learning Network
News
Opioid Dependence Drug Recalled for Subpotency
07/16/2021
Jolynn Tumolo
Alvogen Inc is recalling a single lot of buprenorphine and naloxone sublingual films because of subpotency.
Alvogen Inc is recalling a single lot of buprenorphine and naloxone sublingual films because of subpotency.
Alvogen Inc is recalling a...
07/16/2021
Pharmacy Learning Network
News
Over 88,000 Anti-Inflammatory Injections Recalled
07/16/2021
Jolynn Tumolo
A Class II recall is active for a prescription anti-inflammatory injection used to treat asthma, nasal polyps, and chronic idiopathic urticaria.
A Class II recall is active for a prescription anti-inflammatory injection used to treat asthma, nasal polyps, and chronic idiopathic urticaria.
A Class II recall is active for...
07/16/2021
Pharmacy Learning Network
News
Sleep Loss Quickly Impairs Mental Well-being
07/14/2021
Jolynn Tumolo
Three consecutive nights of fewer than 6 hours of sleep causes deterioration of mental and physical well-being.
Three consecutive nights of fewer than 6 hours of sleep causes deterioration of mental and physical well-being.
Three consecutive nights of...
07/14/2021
Psych Congress Network
News
AMA Votes Against Insurers Paying Patients to Switch Treatments
07/10/2021
Jolynn Tumolo
The American Medical Association (AMA) will support state and federal legislation to oppose insurance companies offering financial incentives for patients to switch from a prescribed treatment to a payer-preferred treatment following the...
The American Medical Association (AMA) will support state and federal legislation to oppose insurance companies offering financial incentives for patients to switch from a prescribed treatment to a payer-preferred treatment following the...
The American Medical Association...
07/10/2021
First Report Managed Care
News
Mental Health Needs to Be Prioritized Among People With HIV/AIDS, Study Says
07/10/2021
Jolynn Tumolo
“There is an urgent need to prioritize mental health screening and care into all HIV testing and treatment settings,” said Paddy Ssentongo, MD, PhD, researcher and epidemiology doctoral student at Penn State College of Medicine. “Suicide risk...
“There is an urgent need to prioritize mental health screening and care into all HIV testing and treatment settings,” said Paddy Ssentongo, MD, PhD, researcher and epidemiology doctoral student at Penn State College of Medicine. “Suicide risk...
“There is an urgent need to...
07/10/2021
First Report Managed Care
News
Interventions for Timely Antibiotic Review in Acute Care Hospitals Appears Effective
07/10/2021
Jolynn Tumolo
Physician-targeted interventions for the timely review of antibiotics in acute care hospitals were effective over the short and medium term, according to a systematic review of 14 studies.
Physician-targeted interventions for the timely review of antibiotics in acute care hospitals were effective over the short and medium term, according to a systematic review of 14 studies.
Physician-targeted interventions...
07/10/2021
First Report Managed Care
News
Examining a Predictive Payer Model for Unplanned Health Care Utilization
07/10/2021
Jolynn Tumolo
Although combined claims and PROMIS data offered some predictive improvement, researchers concluded it was “likely not to an extent that indicates improved practical utility for payers.”
Although combined claims and PROMIS data offered some predictive improvement, researchers concluded it was “likely not to an extent that indicates improved practical utility for payers.”
Although combined claims and...
07/10/2021
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
November 6 ⁠–⁠ November 8
NEI Congress
November 7 ⁠–⁠ November 10
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use